Development of a laboratory network for confirmatory testing of hepatitis C virus infection using HCV viral load quantification methods between 2022 and 2024
DOI:
https://doi.org/10.14456/taj.2026.10Keywords:
laboratory network, viral hepatitis, hepatitis C virus, HCV viral load quantificationAbstract
This report presents the results of the development of a laboratory network for confirmatory testing of hepatitis C virus infection, aiming to improve service accessibility in line with the Public Health Laboratory concept, support confirmatory testing services for individuals with positive screening results, and to facilitate the implementation of the Department of Disease Control's policies. The implementation was conducted in three phases: a pilot phase, a service development phase, and a scale-up phase, by providing HCV viral load testing reagents for a total of 10,796 tests, with a budget of 12.5 million baht over a three-year period (2022-2024), including capacity development, technical consultation, and laboratory quality assurance. The network expanded from 10 facilities (2022) to 52 facilities (2024). Data from the National Health Security Office (NHSO) indicate that the number of service sites increased from 23 facilities (2021) to 399 facilities (2024), representing an increase of more than 17 folds. Moreover, the number of services increased from 1,182 service visits in 2021 to 26,667 service visits in 2024, representing more than a 22-fold increase. After three years of implementation, a survey of hepatitis confirmatory testing services was conducted in 2025. Out of 159 respondents, after data verification, 75 facilities across 56 provinces were found to be providing confirmation testing services, as follows: (1) 60 facilities in 48 provinces provided confirmation testing services for both hepatitis B and C; (2) 2 facilities in two provinces provided confirmation testing services for hepatitis B; and (3) 13 facilities in 11 provinces provided confirmatory testing services for hepatitis C. The main limitations include the cost burden, procurement process, referral system, and reimbursement system for service fees. Therefore, further development of the sample referral system, capacity building for personnel, sustained budget support, and continuous public awareness campaigns are recommended to achieve the goal of hepatitis elimination by 2030.
Downloads
References
World Health Organization. Hepatitis [Internet]. 2024 [cited 2025 May 19]. Available from: https://www.who.int/health-topics/hepatitis#tab=tab_1
World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization; 2024.
World Health Organization. Hepatitis C [Internet]. 2024 [cited 2024 Dec 4]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030. Geneva: World Health Organization; 2022. 1-134 p.
F. Hoffmann-La Roche. cobas® HCV, quantitative nucleic acid test for use on the cobas® 5800/6800/8800 systems [Internet]. 2025 [cited 2025 May 26]. Available from: https://diagnostics.roche.com/global/en/products/lab/cobas-hcv-58-68-88-rmd-58-68-88-hcv.html
Abbott. Abbott RealTime HCV [Internet]. 2025 [cited 2025 May 26]. Available from: https://www.molecular.abbott/content/dam/add/molecular/products/infectious-disease/realtime-hcv-viral-load/realtime-hcv-package-insert.pdf
Cepheid. Xpert® HCV viral load [Internet]. 2025 [cited 2025 May 26]. Available from: https://www.cepheid.com/en-GB/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.html
F. Hoffmann-La Roche. cobas® HBV RNA, quantitative nucleic acid test for use on the cobas® 5800/6800/8800 systems [Internet]. 2025 [cited 2025 May 26]. Available from: https://diagnostics.roche.com/global/en/products/lab/cobas-hbv-rna-test-5800-6800-8800-pid00000472.html
Abbott. Abbott RealTime HBV [Internet]. 2025 [cited 2025 May 26]. Available from: https://www.molecular.abbott/content/dam/add/molecular/products/infectious-disease/realtime-hbv-package-insert.pdf
Cepheid. Xpert® HBV viral load [Internet]. 2025 [cited 2025 May 26]. Available from: https://www.cepheid.com/en-LU/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.html
Hajarizadeh B, George J, Levy MT, Wong I, Howell J, Cabrera G, et al. Evaluation of fingerstick blood point-of-care testing of hepatitis B DNA for enhanced hepatitis B treatment decision making: a diagnostic accuracy study. J Clin Microbiol [Internet]. 2026 [cited 2025 May 26];64(2):e01405-25. Available from: https://doi.org/10.1128/jcm.01405-25
Cepheid. Xpert® HCV VL fingerstick [Internet]. 2025 [cited 2025 May 26]. Available from: https://www.cepheid.com/en-CY/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.html
National Health Security Office. Announcement of the National Health Security Office on payment for public health services for hepatitis C, B.E. 2566 (2023). Royal Thai Government Gazette [Internet]. 2023 [cited 2025 May 26];140(Special Part 63 Ngor):31-4. Available from: https://www.nhso.go.th/th/docman-document/nhso-payment-condition/nhso-payment-medical-services-fees-per-person/2568-2/54798-36-2/file (in Thai)
National Health Security Office. Notification of the National Health Security Office Subject: payment for public health service expenditures for hepatitis C services (No. 2), B.E. 2566 (2023). Royal Thai Government Gazette [Internet]. 2023 [cited 2025 May 26];140(Special Part 224 Ngor):13-5. Available from: https://www.nhso.go.th/en/docman-document/nhso-payment-condition/nhso-payment-service-fees-hiv-aids-patients/518-2-2-2-51-3/file (in Thai)
Kela-Murphy N, Moore MS, Verma CM, Bresnahan MP, Harrison E, Schwartz J, et al. The Hepatitis C clinical exchange network: a local health department partnership with acute care hospitals to promote screening and treatment of hepatitis C virus infection. J Public Health Manag Pract. 2022;28(2):E413-20.
Merrick R, Hinrichs SH, Meigs M. Public health laboratories. In: Magnuson JA, Dixon BE. Public Health Informatics and Information Systems. Cham: Springer Nature; 2013. p. 295-308.
Lertpiriyasuwat C, Jiamsiri S, Dithapan W, Nuchtean T, Srisawat K, Wanthong R, et al. Viral hepatitis B and C screening by collaboration of local administrative organization, 2022-2023. Disease Control Journal. 2024;50(4):587-99 (in Thai)
Department of Disease Control. DDC E-learning system: hepatitis B and C screening services [Internet]. 2023 [cited 2025 Jun 6]. Available from: https://academy.ddc.moph.go.th/moodle/ (in Thai)
National Health Security Office. Dashboard - public health service for HCV [Internet]. 2025 [cited 2025 Jun 10]. Available from: https://medata.nhso.go.th/appcenter/org/hcv (in Thai)
NHS England. Hepatitis C care clinical network specification [Internet]. 2023 [cited 2026 Jun 11]. Available from: https://www.england.nhs.uk/wp-content/uploads/2024/05/PRN231105-hepatitis-c-network-specification-2023-.pdf
World Health Organization. Updated recommendations on HCV simplified service delivery and HCV diagnostics: policy brief. Geneva: World Health Organization; 2022.
Gunsolus IL, Prostko J, Pearce S, Degaga B, Eickstead S, Taylor R, et al. Comparison of a hepatitis C core antigen assay to nucleic acid amplification testing for detection of hepatitis C viremia in a US population. Microbiol Spectr. 2024;12(11):e0097524.